Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion-Reference-Cited by-同舟云学术

Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion

Published:2009-11-16 Issue:1 Volume:26 Page:129-137
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Arnold L.E.¹,Bozzolo D.R.¹,Hodgkins P.²,McKay M.²,Beckett-Thurman L.³,Greenbaum M.⁴,Bukstein O.⁵,Patel A.⁶

Affiliation:

1. The Ohio State University, Columbus, OH, USA

2. Shire Development, Inc., Wayne, PA, USA

3. IPS Research Company, Oklahoma City, OK, USA

4. Capstone Clinical Research, Libertyville, IL, USA

5. University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

6. PCSD-Feighner Research, San Marcos, CA, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007990903437412

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients;CNS Spectrums;2021-04-12

2. Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder;JAMA Pediatrics;2019-07-01

3. New Formulations of Stimulants: An Update for Clinicians;Journal of Child and Adolescent Psychopharmacology;2019-06-01

4. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies;Cochrane Database of Systematic Reviews;2018-05-10

5. Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS);CNS Drugs;2014-02-15